A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Clinical trial NCT03800836 · COMPLETED
Trial details
- NCT number
- NCT03800836
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-13
- Primary completion
- 2022-03-16
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.